OBL Pharm was established in 1994. Production is located in Obolensk, Moscow Region, and covers an area of 2.5 hectares. The production site covers an area of 3,500 sq.m, and the warehouse area covers 2,500 sq.m.
The production activity of OBL Pharm is carried out on the basis of Pharmaceutical Production License No. 00165-LS issued by the Ministry of Industry and Trade of the Russian Federation.
The main goal of the Company is the development and production of high-quality, effective and safe pharmaceuticals that are in demand and competitive in the pharmaceutical market. The company uses an integrated Pharmaceutical Quality System that meets the requirements of the rules of Good Manufacturing Practices (GMP) and ISO 9001.
The main activity of OBL Pharm is the production and packaging of solid dosage formulations (tablets, coated tablets and prolonged-release tablets and capsules) of various pharmaco-therapeutic groups (venotonic, gastrointestinal, analgesic, anti-inflammatory, antimicrobial, antiviral and others).
The Innovative Technologies Development Department is an integrated research and development centre in the field of pharmacy, and is equipped with: